Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3280
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00485485 | Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer | ||
| NCT04095923 | A Social Media Game to Increase Physical Activity Among Older Adult Women | ||
| NCT00504374 | Gene Polymorphisms and Symptoms in Lung Cancer Patients | ||
| NCT04128748 | Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome | ||
| NCT00414310 | Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) | ||
| NCT01095913 | Fluorescent Dyes for Lymph Node Mapping | ||
| NCT00933426 | Lenalidomide and Paclitaxel in Prostate Cancer | ||
| NCT03023215 | Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy | ||
| NCT00081874 | RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma | ||
| NCT07553390 | Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers | ||
| NCT00801489 | Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome | ||
| NCT03465774 | Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions | ||
| NCT01295931 | Nuclear and Near-Infrared (NIR) Imaging in Melanoma | ||
| NCT01471067 | Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | ||
| NCT00038675 | Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | ||
| NCT02948101 | PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | ||
| NCT00003075 | Fenretinide in Treating Patients With Cervical Neoplasia | ||
| NCT03830151 | Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors | ||
| NCT00221039 | Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A | ||
| NCT04774744 | Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia | ||
| NCT02221700 | Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies | ||
| NCT00476294 | Long-Term Follow Up Study for AMD3100 Patients | ||
| NCT00526331 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | ||
| NCT00003239 | Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia | ||
| NCT01893372 | Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) | ||
| NCT04995172 | Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung Lesion | ||
| NCT00242502 | Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery | ||
| NCT01318564 | Diabetic Treatment Adherence | ||
| NCT03452930 | Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma | ||
| NCT02629809 | Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia | ||
| NCT05036681 | A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma | ||
| NCT04533919 | Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia | ||
| NCT03318900 | T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer | ||
| NCT05615636 | A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL | ||
| NCT02272595 | Rational Therapeutics Based on Matched Tumor and Normal Tissue | ||
| NCT04426201 | InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) | ||
| NCT05038839 | Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors | ||
| NCT03668769 | Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking | ||
| NCT02519322 | Neoadjuvant and Adjuvant Checkpoint Blockade | ||
| NCT04150939 | Cryoablation for the Treatment of Metastatic Cancer | ||
| NCT01087983 | Lapatinib With Sirolimus or Metformin | ||
| NCT01365156 | Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix | ||
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | ||
| NCT05496972 | Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology | ||
| NCT04169737 | Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
| NCT03784677 | A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors | ||
| NCT02724956 | Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients | ||
| NCT01950351 | Hypofractionated Proton Beam Therapy for Localized Prostate Cancer | ||
| NCT03283046 | Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT00965341 | Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients |
